[{"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87076", "recalling_firm": "Complete Pharmacy and Medical Solutions, LLC.", "address_1": "5829 Nw 158th St", "address_2": "N/A", "postal_code": "33014-6721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0237-2021", "product_description": "HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035", "product_quantity": "2400 vials", "reason_for_recall": "CGMP deviations: Lack of potency testing.", "recall_initiation_date": "20201120", "center_classification_date": "20210119", "termination_date": "20220928", "report_date": "20210127", "code_info": "Lot #: 40548, Use By Date, 01/30/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0215-2021", "product_description": "HYDROmorphone HCl 10mg/50mL in 0.9% Sodium Chloride Injection, CII, Rx Only, 50 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004030022", "product_quantity": "428 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot #    1220023220, BUD 1/31/2021;  1220023337, BUD 2/2/2021 &  1220023443, BUD 2/22/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0189-2021", "product_description": "ePHEDrine Sulfate 50 mg/10mL in 0.9% Sodium Chloride Injection, 10 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095 barcode 70004060412", "product_quantity": "7,257 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220022996, BUD 1/21/2021; 1220023017, BUD 1/20/2021; 1220023021, BUD 1/17/2021; 1220023033, BUD 1/19/2021; 1220023146, BUD 1/26/2021; 1220023189, BUD 1/27/2021 1220023242, BUD 1/25/2021;  1220023321, BUD 2/2/2021; 1220023357 BUD 2/10/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86929", "recalling_firm": "US Compounding Inc", "address_1": "1270 Dons Ln", "address_2": "N/A", "postal_code": "72032-4753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0175-2021", "product_description": "Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800) 718-3588  NDC 62295-3324-05", "product_quantity": "1640 syringes", "reason_for_recall": "Labelling: Missing label.", "recall_initiation_date": "20201125", "center_classification_date": "20201229", "termination_date": "20211105", "report_date": "20210106", "code_info": "Lot: 20202109@3 BUD: 3/20/2021"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017514"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["ICU Medical Inc."], "product_ndc": ["0990-6138", "0990-7138", "0990-7972"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["486515"], "spl_id": ["ea49c260-0be5-48b8-9e97-bef5a4ca584e"], "spl_set_id": ["3cfdeee0-ff14-4341-8396-b11c2a037c60"], "package_ndc": ["0990-7138-09", "0990-7138-36", "0990-6138-22", "0990-6138-03", "0990-7972-05", "0990-7972-07"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "87484", "recalling_firm": "ICU Medical Inc", "address_1": "600 N Field Dr", "address_2": "N/A", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA to include Puerto Rico", "recall_number": "D-0313-2021", "product_description": "0.9% SODIUM CHLORIDE Irrigation, USP 1000 mL Semi-Rigid Bottle, Rx only, Manufactured for ICU Medical, Inc., Lake Forest, Illinois, 60045 USA. NDC 0990-7138-09", "product_quantity": "425,628 bottles", "reason_for_recall": "Presence of particulate matter.one confirmed  customer report of particulate matter within two semi-rigid bottles identified prior to use", "recall_initiation_date": "20210309", "center_classification_date": "20210325", "termination_date": "20220928", "report_date": "20210331", "code_info": "Lots: 16-808-4B, 16-803-4B, 16-809-4B, Exp. April 01, 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87452", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-0309-2021", "product_description": "Romidepsin Injecton, 27.5 mg/5.5 mL (5 mg/mL) Rx Only, 5.5 ml vial, Teva Pharmaceuticals USA, Inc. NDC 0703-4004-01", "product_quantity": "1,416 vials", "reason_for_recall": "Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities during stability testing.", "recall_initiation_date": "20210304", "center_classification_date": "20210319", "termination_date": "20220519", "report_date": "20210324", "code_info": "Lot # 31328184C, exp. date 11/2021  Lot # 31327686C, exp. date 08/2021  Lot # 31327685C, exp. date 08/2021"}, {"status": "Terminated", "city": "Rahway", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206829"], "brand_name": ["ZERBAXA"], "generic_name": ["CEFTOLOZANE AND TAZOBACTAM"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "product_ndc": ["67919-030"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CEFTOLOZANE SULFATE", "TAZOBACTAM SODIUM"], "rxcui": ["1597615", "1597620"], "spl_id": ["22bf0411-3002-43cd-a13f-1a18b519e0ae"], "spl_set_id": ["70ac1d90-eff3-4f0b-9f46-5846c571b32f"], "package_ndc": ["67919-030-01"], "is_original_packager": [true], "unii": ["7R247U84HY", "UXA545ABTT"]}, "product_type": "Drugs", "event_id": "87018", "recalling_firm": "Merck Sharp & Dohme", "address_1": "126 E Lincoln Ave", "address_2": "", "postal_code": "07065-4607", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0176-2021", "product_description": "Zerbaxa (ceftolozane and tazobactam) 1.5g per vial for injection, Single-Dose vial, Rx only, Manuf. for: Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc., NDC 67919-030-01", "product_quantity": "106,503 vials", "reason_for_recall": "Lack of assurance of sterility: The results of sterility tests of seven batches of product were out of specification. Five of these batches tested positive for Ralstonia pickettii and two batches produced turbid results that could not be further identified. While all product distributed to the market has met the registered specifications for release, including for sterility, it was manufactured on the same equipment as the affected batches.", "recall_initiation_date": "20201221", "center_classification_date": "20210107", "termination_date": "20231204", "report_date": "20210113", "code_info": "All lots within expiry:  SP1488 08-Jun-21; SP1490 11-Jun-21; SP1492 13-Jun-21; SP1493 15-Jun-21; SP1494 21-Jun-21; SP1495 23-Jun-21; SP1496 25-Jun-21; SP1497 27-Jun-21; SP1498 29-Jun-21; SP1509 20-Sep-21; SP1510 26-Sep-21; SP1515 16-Oct-21; SP1517 23-Oct-21; SP1518 25-Oct-21; SP1519 30-Oct-21; SP1520 01-Nov-21; SP1521 06-Nov-21; SP1522 08-Nov-21; SP1523;13-Nov-21; SP1524; 15-Nov-21; SP1525 20-Nov-21; SP1526 27-Nov-21; SP1537 11-Jan-22; SP1564 17-Oct-22; SP1567 16-Oct-22; SP1572 24-Oct-22; SP1573; 28-Oct-22; SP1574  29-Oct-22; SP1584; 14-Nov-22; SP1586; 15-Nov-22; SP1588; 19-Nov-22; SP1593 03-Dec-22; SP1602 18-Dec-22; SP1603; 19-Dec-22; SP1606 08-Jan-23; SP1609 15-Jan-23; SP1610 20-Jan-23; SP1611 22-Jan-23; SP1626 13-Apr-23; SP1629  17-Apr-23; SP1633 21-Apr-23", "more_code_info": ""}, {"status": "Terminated", "city": "Atlanta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87268", "recalling_firm": "Wilshire Pharmaceuticals Inc", "address_1": "6 Concourse Pkwy NE", "address_2": "N/A", "postal_code": "30328-6117", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, TX", "recall_number": "D-0258-2021", "product_description": "Meclizine HCl Tablets, USP, 12.5 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-129-01", "product_quantity": "2112 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20210204", "center_classification_date": "20210216", "termination_date": "20230602", "report_date": "20210224", "code_info": "Lot #: 18030318, Exp 03/2021"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0216-2021", "product_description": "PHENYLephrine HCl 5000 mg/50 mL in Sodium Chloride 0.9% (100 mcg/mL) Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004081022", "product_quantity": "3152 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023003, BUD 12/22/2020;  1220023057, BUD  12/25/2020;  1220023104, BUD  12/25/2020;  1220023144, BUD  12/27/2020;  1220023168, BUD 12/27/2020;  1220023222, BUD 12/29/2020;  1220023240, BUD 12/28/2020;  1220023284, BUD 1/1/2021;  1220023456, BUD 1/8/2021;  1220023474, BUD 1/4/2021;  1220023530, BUD 1/8/2021 &  1220023542, BUD 1/9/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87093", "recalling_firm": "Bausch Health Companies, Inc.", "address_1": "400 Somerset Corporate Blvd", "address_2": "", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0244-2021", "product_description": "Phytonadione Tablets 5mg, 30-count bottle, Rx Only, Manufactured For: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA NDC 68682-170-30", "product_quantity": "14,089 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.", "recall_initiation_date": "20210107", "center_classification_date": "20210125", "termination_date": "20220211", "report_date": "20210203", "code_info": "Lot: 18L091P, Exp 05/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0213-2021", "product_description": "ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride Injection, Rx Only, 5 mL Single Dose Syringe,  SCA Pharmaceuticals 8521 Knoedl Ct., Little Rock, AR, 72205, barcode 70004060409", "product_quantity": "9416 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot #    1220023022, BUD 1/17/2021;  1220023023, BUD 1/17/2021;  1220023029, BUD 1/19/2021;  1220023030, BUD 1/20/2021;  1220023117, BUD 1/25/2021;  1220023145, BUD 1/26/2021 &  1220023166, BUD 1/27/2021.", "more_code_info": ""}, {"status": "Ongoing", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076756"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Nostrum Laboratories Inc."], "product_ndc": ["29033-055", "29033-056"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["34afc382-4296-4212-9bde-babe51e8575d"], "spl_set_id": ["01b1ad34-bee2-461e-b5f5-0b0cf90dfe0b"], "package_ndc": ["29033-055-01", "29033-055-05", "29033-055-10", "29033-056-01", "29033-056-10"], "is_original_packager": [true], "upc": ["0329033056014"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "87210", "recalling_firm": "Nostrum Laboratories Inc", "address_1": "1800 N Topping Ave", "address_2": "", "postal_code": "64120-1228", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0249-2021", "product_description": "Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120.  NDC: 29033-056-01", "product_quantity": "7071 bottles", "reason_for_recall": "CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.", "recall_initiation_date": "20210125", "center_classification_date": "20210204", "report_date": "20210210", "code_info": "Lot MET200601, 07/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0191-2021", "product_description": "fentaNYL 100 mcg/50mL Ropivacaine HCl 0.1% in 0.9% Sodium Chloride 50 mL, 50 mL Single Dose Syringe, Rx Only,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004026422", "product_quantity": "1,774 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023275, BUD 2/15/2021; 1220023312, BUD 2/15/2021; 1220023433, 2/22/2021;  1220023515, BUD 2/24/2021 & 1220023671, BUD 3/1/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0207-2021", "product_description": "Sodium Citrate 4% 3 mL Anticoagulation Solution (40mg/mL), Rx only, 3 mL Single Dose Syringe,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004090025", "product_quantity": "5,990 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220022961, BUD 1/20/2021; 1220023121, BUD 1/25/2021; 1220023207, BUD 2/12/2021; 1220023363, BUD 2/17/2021 & 1220023526, BUD 2/23/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0280-2021", "product_description": "Epoprostenol Sodium for Injection, 1.5 mg/vial (1,500,000 ng), 10 mL vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-1995-01.", "product_quantity": "12,609 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31326456B, exp. date 02/28/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA073135"], "brand_name": ["METOCLOPRAMIDE"], "generic_name": ["METOCLOPRAMIDE"], "manufacturer_name": ["Teva Parenteral Medicines, Inc."], "product_ndc": ["0703-4502"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METOCLOPRAMIDE HYDROCHLORIDE"], "rxcui": ["311670"], "spl_id": ["e640a87c-7ee3-4ca2-9808-3916bfd1a54b"], "spl_set_id": ["cccf04bd-7463-40b8-a41f-cb1093c358d7"], "package_ndc": ["0703-4502-01", "0703-4502-04"], "is_original_packager": [true], "unii": ["W1792A2RVD"]}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0277-2021", "product_description": "Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL Single-Use Vials per tray (NDC 0703-4502-04), Rx only, Teva Parenteral Medicines, Inc., Irvine, CA  92618.", "product_quantity": "29,357 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot #   31325042B, exp. date 06/2021  31325336B, exp. date  07/2021  31326042B, exp. date  10/2021  31326137B, exp. date  11/2021  31326230B, exp. date  12/2021  31323816B, exp. date  02/2021"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87154", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0232-2021", "product_description": "Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100 per carton (10 capsules x 10 blister cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC Carton: 68084-446-01; NDC Blister Card: 68084- 446-11", "product_quantity": "1948 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20210107", "center_classification_date": "20210115", "termination_date": "20220803", "report_date": "20210127", "code_info": "Lot # 193757, Exp 1/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0273-2021", "product_description": "Sterile Diluent for Epoprostenol Sodium for Injection, 50 mL vial (NDC 0703-9258-01), packaged in 2X50ML per tray (NDC 0703-9258-09), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA  19454.", "product_quantity": "26,373 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31326845B, exp. date 03/2021  Lot # 31327844B, exp. date 09/2021"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87269", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0261-2021", "product_description": "Enoxaparin Sodium Injection, USP 100 mg/mL Single Dose Syringes with Automatic Safety Device For Subcutaneous Injection 10 x 1 mL Single Dose Syringes Rx Only, Manufactured by: Gland Pharma Ltd. Hyderabad, India Manufactured for: Apotex Corp. Weston, FL 33326   NDC 60505-0795-4 UPC 360505079544 (carton) NDC 60505-0795-1 UPC (01)10360505079510 (label)", "product_quantity": "6670 cartons", "reason_for_recall": "Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength)", "recall_initiation_date": "20210202", "center_classification_date": "20210217", "report_date": "20210217", "code_info": "Batch: CS008 Exp. 04/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208801"], "brand_name": ["PROGESTERONE"], "generic_name": ["PROGESTERONE"], "manufacturer_name": ["Dr. Reddys Laboratories, Inc."], "product_ndc": ["43598-349", "43598-350"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROGESTERONE"], "rxcui": ["260243", "312641"], "spl_id": ["4b8f3d16-f096-32f0-65f9-230ab8c292b7"], "spl_set_id": ["efded380-02ff-68c9-13e4-47a561ede440"], "package_ndc": ["43598-349-01", "43598-350-01"], "is_original_packager": [true], "nui": ["M0017672", "N0000175601"], "pharm_class_cs": ["Progesterone [CS]"], "pharm_class_epc": ["Progesterone [EPC]"], "unii": ["4G7DS2Q64Y"]}, "product_type": "Drugs", "event_id": "87411", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0292-2021", "product_description": "Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540; NDC 43598-350-01.", "product_quantity": "16,449 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.", "recall_initiation_date": "20210226", "center_classification_date": "20210303", "termination_date": "20220217", "report_date": "20210310", "code_info": "Batch # 1399851P1, Exp 02/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0202-2021", "product_description": "morphine sulfate 150 mg/30 mL in 0.9% Sodium Chloride Injection, (5 mg/mL), Rx Only, 30 mL Single Dose Syringe,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010316", "product_quantity": "50 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023221, BUD 1/31/2021 &  1220023584, BUD 2/9/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Paramount", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87257", "recalling_firm": "DLC Laboratories, Inc", "address_1": "7008 Marcelle St", "address_2": "N/A", "postal_code": "90723-4839", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide and to the following foreign countries: Canada, Cambodia, Germany, and United Kingdom.", "recall_number": "D-0257-2021", "product_description": "Sulfur Ointment 10%, Pomada de Azufre, 2.6 OZ (73.7g) jar; Manufactured by/ Fabricado por: De La Cruz Products, A Division of DLC Laboratories, Inc. Paramount, CA 9023 USA; UPC 024286150426", "product_quantity": "86,297 jars", "reason_for_recall": "Labeling: Label Mix-Up. THe English label with Drug Facts panel for Camphor was incorrectly placed on product.", "recall_initiation_date": "20210106", "center_classification_date": "20210212", "termination_date": "20220923", "report_date": "20210224", "code_info": "Lot # 5084, Exp 05/23; 5130, Exp 07/23; 5132, Exp 07/23; 5160, Exp 08/23."}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0188-2021", "product_description": "ePHEDrine Sulfate, 50 mg/5mL in 0.9% Sodium Chloride Injection, 5 mL Single Dose Syringe, Rx Only,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004060509", "product_quantity": "1,879 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023041, BUD 1/20/2021; 1220023188, BUD 1/27/2021 & 1220023397, BUD 2/3/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0190-2021", "product_description": "Esmolol HCl 100 mg/10 mL (10mg/ mL), 10 mL Single Dose Syringe,  Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd.,  Windsor, CT, 06095, barcode 70004062012", "product_quantity": "952 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023042, BUD 1/21/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Cambridge", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87256", "recalling_firm": "Akebia Therapeutics dba Keryx Biopharmaceutials, Inc", "address_1": "245 1st St", "address_2": "N/A", "postal_code": "02142-1200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0260-2021", "product_description": "Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., 245 First Street, Suite 1400, Cambridge, MA 02142, USA, NDC 59922-0631-01.", "product_quantity": "17,664 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20210129", "center_classification_date": "20210217", "termination_date": "20220210", "report_date": "20210224", "code_info": "Lots #: CDKSN, CDPPH, Exp January 2022;  Lot #: CDPPK, Exp February 2022."}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0194-2021", "product_description": "Glycopyrrolate 1 mg/5mL (0.2mg/mL), 5 mL Single Dose Syringe, Rx Only,  SCA Pharmaceuticals,  755 Rainbow Rd.,  Windsor, CT,  06095, barcode 70004063809", "product_quantity": "1,614 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023043, BUD 2/3/2021; 1220023141, BUD 2/9/2021; 1220023429, BUD 2/18/2021 & 1220023470, BUD 2/18/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87029", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "N/A", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0177-2021", "product_description": "Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979", "product_quantity": "6520 vials", "reason_for_recall": "Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.", "recall_initiation_date": "20201217", "center_classification_date": "20201230", "termination_date": "20230823", "report_date": "20210106", "code_info": "Lot#: 20JUN010, Exp 5/12/21"}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87052", "recalling_firm": "Sunstar Americas, Inc.", "address_1": "301 E Central Rd", "address_2": "N/A", "postal_code": "60195-1901", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide USA", "recall_number": "D-0222-2021", "product_description": "Paroex (Chlorhexidine Gluconate) Oral Rinse, USP 0.12%, Alcohol Free, Rx only, packaged in: a) 1 pint (473mL) NDC 52376-021-02; b) 4 fl oz (118 mL) NDC 052376-021-04, Sunstar Americas, Inc., Schaumburg, IL", "product_quantity": "a) 1,021,914 bottles; b) 255,552 bottles", "reason_for_recall": "cGMP Deviations; FDA inspection of manufacturing facility observed potential Burkholderia cepacia complex (BCC) contamination, inadequate cleaning, inadequate microbiological testing, and insanitary conditions", "recall_initiation_date": "20201228", "center_classification_date": "20210111", "report_date": "20210120", "code_info": "ALL LOTS with expiration date from Dec. 31, 2020 through Sep. 30, 2022"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0214-2021", "product_description": "fentaNYL 100 mcg/2mL Injection for IV or IM Use, 2 mL Single Dose Syringe, CII, Rx Only,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095    barcode 70004020006", "product_quantity": "6710 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot #1220023109, BUD 1/25/2021;  1220023255, BUD 1/26/2021;  1220023256. BUD 1/26/2021;  1220023257, BUD 1/28/2021;  1220023334, BUD 2/2/2021 &  1220023518, BUD 2/8/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211751"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-528", "69097-529"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM DIHYDRATE"], "rxcui": ["692576", "692578"], "spl_id": ["e64d9eeb-1821-4520-9325-8b006fec057f"], "spl_set_id": ["c1319da6-bf0d-4dd6-a713-1677bfbfbdae"], "package_ndc": ["69097-528-34", "69097-529-34"], "is_original_packager": [true], "unii": ["36H71644EQ"]}, "product_type": "Drugs", "event_id": "87038", "recalling_firm": "CIPLA", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0183-2021", "product_description": "Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059 NDC 69097-529-34", "product_quantity": "6,491 packets", "reason_for_recall": "Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline", "recall_initiation_date": "20201217", "center_classification_date": "20201230", "termination_date": "20221207", "report_date": "20210106", "code_info": "Lot #: KA00415, KA00416, Exp 11/2021"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206547"], "brand_name": ["IMATINIB"], "generic_name": ["IMATINIB"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "product_ndc": ["43598-344", "43598-345"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IMATINIB MESYLATE"], "rxcui": ["403878", "403879"], "spl_id": ["38a9944b-db90-72f2-3f0b-7767da490ae2"], "spl_set_id": ["559dd8e5-11f9-70cd-3fb0-9f9eb8484a37"], "package_ndc": ["43598-344-30", "43598-344-90", "43598-344-10", "43598-344-31", "43598-345-30", "43598-345-90", "43598-345-05", "43598-345-31"], "is_original_packager": [true], "unii": ["8A1O1M485B"]}, "product_type": "Drugs", "event_id": "87339", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0287-2021", "product_description": "Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For Institutional Use Only 30-count (3 x 10 unit-dose) tablets per carton (NDC 43598-344-31); Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540; Made in India.", "product_quantity": "a) 1350 bottles; b) 147 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20210217", "center_classification_date": "20210224", "termination_date": "20221221", "report_date": "20210303", "code_info": "Lot #: a) H2000206, Exp 06/22; b) H2000138, Exp 06/22"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86998", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in Puerto Rico and Oman", "recall_number": "D-0266-2021", "product_description": "ChloraPrep With Tint 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution - Hi-Lite Orange, 0.10 fl. oz. (3 ml) each, 25 applicators in carton, CareFusion El Paso, TX 79912, NDC 054365-400-11 Cat. No. 260415", "product_quantity": "36 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Products:Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20200707", "center_classification_date": "20210219", "termination_date": "20220929", "report_date": "20210303", "code_info": "All lots including but not limited to the following lots distributed in Zone IV: Lot # 0038209, Exp. 01/31/2023; 0098528, Exp. 02/28/2023."}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0186-2021", "product_description": "Atropine Sulfate Injection, 0.8 mg/2 mL (0.4 mg/mL), 2 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT,  06095, barcode 70004004006", "product_quantity": "1,930 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023001, BUD 2/5/2021; 1220023126, BUD 2/9/2021 & 1220023606, BUD 2/25/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0199-2021", "product_description": "Lidocaine HCl 1% 10 mL (10mg/ml), Rx Only, 1 mL Single Dose Syringe,  SCA Pharma, Inc., 755 Rainbow Rd., Windsor, CT, 06095,  barcode 70004072012", "product_quantity": "1,880 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023097, BUD 1/25/2021; 1220023134, BUD 1/25/2021 & 1220023326, BUD 2/1/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0203-2021", "product_description": "neostigmine methylsulfate 5 mg/5 mL, (1mg/ml), Rx Only,  5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004075009", "product_quantity": "390 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023044, BUD 1/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87051", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0221-2021", "product_description": "Levetiracetam Oral Solution, 100 mg/mL, 16 fl oz (473 mL) bottle, Rx Only, HI-TECH PHARMACAL CO., INC., Amityville, NY 11701; NDC 50383-241-16", "product_quantity": "22,248 bottles", "reason_for_recall": "Defective container: Customer complaints for oral solution leaking from bottles.", "recall_initiation_date": "20201228", "center_classification_date": "20210111", "termination_date": "20220809", "report_date": "20210120", "code_info": "Lot #: 373859, 373863, and 373865, Exp 05/2022; 374586, Exp 06/2022"}, {"status": "Terminated", "city": "South Beloit", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87081", "recalling_firm": "Precision Dose Inc.", "address_1": "722 Progressive Ln", "address_2": "N/A", "postal_code": "61080-2616", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-0228-2021", "product_description": "Chlorhexidine Gluconate Oral Rinse USP 0.12%, packaged in a) 15 mL x 30 Unit Dose Cups (30-pack case) NDC 68094-028-61, b) 15 mL x 100 Unit Dose Cups (100-pack case) NDC 68094-028-62, Rx only, Precision Dose, Inc., South Beloit, IL 61080.", "product_quantity": "1,107,510 unit dose cups", "reason_for_recall": "cGMP deviations: The firm was notified of the manufacturer's expanded recall.", "recall_initiation_date": "20210101", "center_classification_date": "20210114", "termination_date": "20240714", "report_date": "20210120", "code_info": "Lot #: a) 502037, 502040, 502043, Exp 1/31/2021; 502494, 502757, Exp 8/31/2021; 502677, Exp 9/30/2021; 502693, 502728, Exp 10/31/2021; 502771, 502784, Exp 11/30/2021; 502824, Exp 12/31/2021; 502925, Exp 2/28/2022; b) 502037, 502040, 502043, Exp 1/31/2021; 502494, Exp 8/31/2021; 502759, Exp 10/31/2021; 502771, Exp 11/30/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0272-2021", "product_description": "Desmopressin Acetate Injection USP, 4 mcg/mL, 1 mL Preserved Vial (NDC 0703-5051-01), packaged in 10X1 mL Vials per Tray (NDC 0703-5051-03), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454.", "product_quantity": "2,577 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31326669B, exp. date 03/2021"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0212-2021", "product_description": "SUCcinylcholine Chloride 100 mg/5mL, Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., WIndsor, CT, 06095, barcode 70004090809", "product_quantity": "5067 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot #    1220023019, BUD 1/17/2021;  1220023025, BUD 1/18/2021;  1220023026, BUD 1/24/2021 &  1220023264, BUD 2/1/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211751"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-528", "69097-529"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM DIHYDRATE"], "rxcui": ["692576", "692578"], "spl_id": ["e64d9eeb-1821-4520-9325-8b006fec057f"], "spl_set_id": ["c1319da6-bf0d-4dd6-a713-1677bfbfbdae"], "package_ndc": ["69097-528-34", "69097-529-34"], "is_original_packager": [true], "unii": ["36H71644EQ"]}, "product_type": "Drugs", "event_id": "87038", "recalling_firm": "CIPLA", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0182-2021", "product_description": "Esomeprazole Magnesium for Delayed-Release Oral Suspension 20mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059, NDC 69097-528-34", "product_quantity": "289350 packets", "reason_for_recall": "Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline", "recall_initiation_date": "20201217", "center_classification_date": "20201230", "termination_date": "20221207", "report_date": "20210106", "code_info": "Lot #: KA00413, KA00414, KA00461, Exp 11/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-544", "67877-545"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309113"], "spl_id": ["84f07b4a-a15e-41cb-af85-e110c5cf342e"], "spl_set_id": ["bb28751c-bd1b-4e7f-8271-a14c1b4314e3"], "package_ndc": ["67877-544-88", "67877-544-68", "67877-545-88", "67877-545-68"], "is_original_packager": [true], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "87214", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0263-2021", "product_description": "Cephalexin for Oral Suspension, USP 250 mg per 5 mL, 100 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88", "product_quantity": "14,205 100 mL bottles", "reason_for_recall": "CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.", "recall_initiation_date": "20210122", "center_classification_date": "20210218", "termination_date": "20221202", "report_date": "20210224", "code_info": "Lot # 19144841, Exp 9/2021; 20141673 Exp 4/2022."}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86997", "recalling_firm": "US Compounding Inc", "address_1": "1270 Dons Ln", "address_2": "N/A", "postal_code": "72032-4753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0223-2021", "product_description": "Succinylcholine Chloride PF Inj. 200 mg/10 mL, 10 mL single use syringes, Rx only, US Compounding, 1270 Don's Lane, Conway, AR 72032", "product_quantity": "1534 syringes", "reason_for_recall": "Labeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible.", "recall_initiation_date": "20201216", "center_classification_date": "20210111", "termination_date": "20211105", "report_date": "20210120", "code_info": "Lot #: 20202010@6 BUD: 02/17/2021"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077674"], "brand_name": ["PANTOPRAZOLE SODIUM"], "generic_name": ["PANTOPRAZOLE SODIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-129"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PANTOPRAZOLE SODIUM"], "rxcui": ["283669"], "spl_id": ["ef1bb9ed-b534-4698-abf5-836dcce85f45"], "spl_set_id": ["d9fcf6a2-3788-4955-84d9-3c319b13267c"], "package_ndc": ["62756-129-40", "62756-129-44", "62756-129-45"], "is_original_packager": [true], "upc": ["0362756129405"], "unii": ["6871619Q5X"]}, "product_type": "Drugs", "event_id": "87260", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0251-2021", "product_description": "Pantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 62756-129-40", "product_quantity": "20,475 vials", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20210205", "center_classification_date": "20210209", "termination_date": "20211103", "report_date": "20210217", "code_info": "JKU3595A, JKU3596A, JKU3597A, and JKU3629A; Exp 02/2021"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075784"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-161", "63323-162"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["ab476c4c-2c72-47b1-bf42-7a89703b0dd4"], "spl_set_id": ["d1920335-8e45-4960-b6e9-e6f1f9e6820c"], "package_ndc": ["63323-161-00", "63323-161-01", "63323-162-11", "63323-162-51", "63323-162-00", "63323-162-01", "63323-162-03", "63323-162-02"], "is_original_packager": [true], "upc": ["0363323162115", "0363323161002", "0363323162009", "0363323162030"], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "87005", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide and Puerto Rico", "recall_number": "D-0184-2021", "product_description": "Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02", "product_quantity": "490,633 vials", "reason_for_recall": "Presence of Particulate Matter - found in reserve sample vials at the firm.", "recall_initiation_date": "20201217", "center_classification_date": "20201231", "termination_date": "20230620", "report_date": "20210106", "code_info": "Batch # 6121125, Exp 02/2021"}, {"status": "Terminated", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86709", "recalling_firm": "Wishgarden Herbs, Incorporated", "address_1": "321 S Taylor Ave Unit 100", "address_2": "N/A", "postal_code": "80027-3600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA, Egypt and Canada.", "recall_number": "D-0218-2021", "product_description": "Happy Ducts Compress, 3 oz. plastic jar, www.wishgardenherbs.com, Boulder, CO. 80301. UPC 6 56490 20223 5", "product_quantity": "46 jars", "reason_for_recall": "Microbial Contamination of a Non-Sterile Product: Product tested positive for Cronobacter Sakazakii.", "recall_initiation_date": "20200925", "center_classification_date": "20210107", "termination_date": "20240529", "report_date": "20210106", "code_info": "Lot # 53664, Exp 08/2022"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-544", "67877-545"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309113"], "spl_id": ["84f07b4a-a15e-41cb-af85-e110c5cf342e"], "spl_set_id": ["bb28751c-bd1b-4e7f-8271-a14c1b4314e3"], "package_ndc": ["67877-544-88", "67877-544-68", "67877-545-88", "67877-545-68"], "is_original_packager": [true], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "87032", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0179-2021", "product_description": "Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68", "product_quantity": "9,524 bottles", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20201217", "center_classification_date": "20201230", "termination_date": "20230503", "report_date": "20210106", "code_info": "20141680, 20141681, 20141759"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87342", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide, including Puerto Rico.", "recall_number": "D-0298-2021", "product_description": "Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03", "product_quantity": "635,400 cartons", "reason_for_recall": "Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.", "recall_initiation_date": "20210219", "center_classification_date": "20210304", "termination_date": "20221115", "report_date": "20210310", "code_info": "Lot #: 20K0043P, 20K0044P, 20K0042P, Exp 08/2022; 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P, Exp 09/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0271-2021", "product_description": "Dacarbazine for Injection USP, 200 mg, Single Use Vial (NDC 0703-5075-01), packaged in 10X20 ML Single Use Vials per tray (NDC 0703-5075-03); Rx only, TEVA Pharmaceuticals USA, INC., North Wales, PA  19454.", "product_quantity": "50 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31326582B, exp. date 02/2022;  Lot # 31326964B, exp. date 04/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091650"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-121", "55111-122", "55111-123"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["617310", "617311", "617312"], "spl_id": ["36e09eff-3948-2638-b633-d5ec2bc03d2a"], "spl_set_id": ["901550e6-22be-68c9-eb86-f85a9c9dd998"], "package_ndc": ["55111-121-30", "55111-121-60", "55111-121-90", "55111-121-05", "55111-121-10", "55111-122-30", "55111-122-60", "55111-122-90", "55111-122-05", "55111-122-10", "55111-123-30", "55111-123-60", "55111-123-90", "55111-123-05", "55111-123-10"], "is_original_packager": [true], "upc": ["0355111123903"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "87365", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0291-2021", "product_description": "Atorvastatin Calcium Tablets, 40mg, packaged in a) 90-count bottles, NDC 55111-123-90; b)  500-count bottles, NDC 55111-123-05; Rx only, Mfd By: Dr. Reddy's Laboratories Limited Srikakulam - 532 409 INDIA", "product_quantity": "10,440 90-count and 224,710 500-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and Dieto epoxy impurities", "recall_initiation_date": "20210219", "center_classification_date": "20210301", "termination_date": "20230907", "report_date": "20210310", "code_info": "a) T900406, exp 3/2021    b) T000078 exp 12/2021  T000079 exp 12/2021  T000080 exp 12/2021  T000081 exp 12/2021  T000082 exp 12/2021  T000083 exp 12/2021  T000084 exp 12/2021  T000085 exp 12/2021  T000086 exp 12/2021  T000087 exp 12/2021  T000088 exp 1/2022  T000311 exp 1/2022  T000312 exp 1/2022  T000313 exp 1/2022  T000314 exp 1/2022  T000315 exp 1/2022  T000316 exp 1/2022  T000317 exp 1/2022  T000318 exp 1/2022  T000319 exp 1/2022  T000320 exp 1/2022  T000500 exp 2/2022  T000501 exp 2/2022  T000502 exp 2/2022  T000503 exp 2/2022  T000504 exp 2/2022  T000505 exp 2/2022  T000506 exp 2/2022  T000507 exp 2/2022  T000508 exp 2/2022  T000509 exp 3/2022  T000510 exp 3/2022  T000647 exp 3/2022  T000648 exp 3/2022  T000651exp 3/2022  T000652 exp 3/2022  T000653 exp 3/2022  T000654 exp 3/2022  T000875 exp 4/2022  T000876 exp 4/2022  T000877 exp 4/2022  T000878 exp 4/2022  T000879 exp 4/2022  T000880 exp 4/2022  T000881 exp 4/2022  T000882 exp 4/2022  T000883 exp 4/2022  T000884 exp 4/2022  T001120 exp 5/2022  T001121 exp 5/2022  T001122 exp 5/2022  T001124 exp 5/2022  T001125 exp 5/2022  T001126 exp 5/2022  T001127 exp 5/2022  T001128 exp 5/2022  T001129 exp 5/2022  T001130 exp 5/2022  T001260 exp 5/2022  T001261 exp 5/2022  T900506 exp 4/2021  T900507 exp 4/2021  T900508 exp 4/2021  T900655 exp 5/2021  T900656 exp 5/2021  T900657 exp 5/2021  T900658 exp 5/2021  T900659 exp 5/2021  T900673 exp 5/2021  T900674 exp 5/2021  T901024 exp 7/2021  T901025 exp 7/2021  T901026 exp 7/2021  T901027 exp 7/2021  T901029 exp 7/2021   T901030 exp 7/2021  T901031 exp 7/2021  T901032 exp 7/2021  T901033 exp 7/2021  T901424 exp 10/2021  T901425 exp 10/2021  T901426 exp 10/2021  T901427 exp 10/2021   T901428 exp 10/2021  T901429 exp 10/2021  T901430 exp 10/2021   T901431 exp 10/2021  T901432 exp 10/2021  T901433 exp 10/2021  T901568 exp 10/2021  T901569 exp 10/2021  T901570 exp 11/2021  T901571 exp 11/2021  T901572 exp 11/2021  T901573 exp 11/2021  T901574 exp 11/2021  T901575 exp 11/2021  T901576 exp 11/2021  T901577 exp 11/2021", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206530"], "brand_name": ["FAMOTIDINE"], "generic_name": ["FAMOTIDINE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-859", "65862-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FAMOTIDINE"], "rxcui": ["284245", "310273"], "spl_id": ["e0c726f6-8257-4dba-b2f9-d78d28097bd9"], "spl_set_id": ["b0798337-1a73-415e-8416-613984ce5c65"], "package_ndc": ["65862-859-30", "65862-859-01", "65862-859-05", "65862-859-99", "65862-859-10", "65862-859-78", "65862-860-30", "65862-860-01", "65862-860-05", "65862-860-99", "65862-860-10", "65862-860-78"], "is_original_packager": [true], "nui": ["N0000000151", "N0000175784"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "unii": ["5QZO15J2Z8"]}, "product_type": "Drugs", "event_id": "87193", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX, CA, GA, PA", "recall_number": "D-0290-2021", "product_description": "Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India, NDC 65862-860-99", "product_quantity": "1296 bottles", "reason_for_recall": "Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.", "recall_initiation_date": "20210120", "center_classification_date": "20210226", "termination_date": "20231012", "report_date": "20210310", "code_info": "Lot #: P2000467, Exp 7/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0279-2021", "product_description": "Vecuronium Bromide for Injection, 10 mg, 1 mg/mL when reconstituted to 10 mL, 10 mL Vial (NDC 0703-2914-01), packaged in 10 x 10 mL Vials per tray (NDC 0703-2914-03), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454.", "product_quantity": "33,6697 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot #   31325712B, exp. date 12/2021  31326320B, exp. date 02/2022  31326457B, exp. date 02/2022  31327880B, exp. date 10/2022"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-544", "67877-545"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309113"], "spl_id": ["84f07b4a-a15e-41cb-af85-e110c5cf342e"], "spl_set_id": ["bb28751c-bd1b-4e7f-8271-a14c1b4314e3"], "package_ndc": ["67877-544-88", "67877-544-68", "67877-545-88", "67877-545-68"], "is_original_packager": [true], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "87214", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0264-2021", "product_description": "Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68", "product_quantity": "23,436 200 mL bottles", "reason_for_recall": "CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.", "recall_initiation_date": "20210122", "center_classification_date": "20210218", "termination_date": "20221202", "report_date": "20210224", "code_info": "Lot #: 19141869, 19141870, EXP 3/2021; 19142762, EXP 5/2021; 19143826, 19143923,19143941, 19143954 EXP 7/2021"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0200-2021", "product_description": "Lidocaine HCl 2% 5 mL, 20 mg/mL, Rx Only, 5 mL syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004072309", "product_quantity": "7,275 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023034, BUD 1/19/2021;  1220023088, BUD 1/24/2021; 1220023112, BUD 1/25/2021;  1220023288, BUD 1/31/2021; 1220023323, BUD 2/2/2021;  1220023539, BUD 2/8/2021 &  1220023613, BUD 2/10/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87093", "recalling_firm": "Bausch Health Companies, Inc.", "address_1": "400 Somerset Corporate Blvd", "address_2": "", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0243-2021", "product_description": "Mephyton (phytonadione) Tablets 5mg, 100-count bottle, Rx Only, Manufactured for: Valeant Pharmaceuticals North America, LLC Bridgewater, NJ 08807 USA NDC 0187-1704-05", "product_quantity": "895 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.", "recall_initiation_date": "20210107", "center_classification_date": "20210125", "termination_date": "20220211", "report_date": "20210203", "code_info": "Lot: 18L092P, Exp 05/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87373", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0296-2021", "product_description": "Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) Contains: 30 Patches in a foil-sealed polypropylene tray,  packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5555-3.", "product_quantity": "934,140 patches", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel.", "recall_initiation_date": "20210219", "center_classification_date": "20210303", "termination_date": "20240705", "report_date": "20210310", "code_info": "Lots #: 87377, Exp 3/2021, 87572, Exp 3/2021, 87581, Exp 4/2021, 87820, Exp 5/2021, 88246, Exp 6/2021, 88535, Exp 7/2021, 88536, Exp 8/2021, 88537, Exp 8/2021 & 88939, Exp 8/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "San Nicolas De Los Georgia", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86078", "recalling_firm": "Liq-E S.A. De C.V.", "address_1": "Puerto Tampico 345", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the United States and Mexico.", "recall_number": "D-0253-2021", "product_description": "OPTIMUS LUBRICANTS  Instant Hand Sanitizer, (ethyl alcohol 70%) 8.5 Fl. Oz. (250 mL) bottle, Made in Mexico, Liq-E, S.A. DE C.V., Puerto Tampico No. 345 Col. La Fe San Nicolas de Los Garza, Nuevo Leon, Mexico. C.P. 66477. UPC # 7 501799 115621", "product_quantity": "12,201 bottles", "reason_for_recall": "Chemical Contamination: Products contain methanol and were below the label claim for ethanol content", "recall_initiation_date": "20200720", "center_classification_date": "20210212", "termination_date": "20240408", "report_date": "20210224", "code_info": "Lot # (L)20-02, exp. date 05/2022"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0275-2021", "product_description": "MethyIPREDNISolone Acetate Injectable Suspension USP,   40 mg/mL, 1 mL Single-Dose Vial (NDC 0703-0031-01), packaged in 25X1ML per tray (NDC 0703-0031-04), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA  19454.", "product_quantity": "5,086 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327742B, exp. date 02/2021  Lot # 31328408B, exp. date 07/2021"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0209-2021", "product_description": "Morphine Sulfate 30 mg/30 mL in 0.9% Sodium Chloride (1mg/ml), CII, Rx Only, 30 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010016", "product_quantity": "116 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023412, BUD 2/2/2021; 12220023500, BUD 2/3/2021 & 1220023689 BUD 2/11/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0197-2021", "product_description": "Ketamine 100 mg/10mL in 0.9% Sodium Chloride Injection (10 mg/mL), CII, Rx Only, 10 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004043012", "product_quantity": "11,075 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "a) Lot # 1220023076, BUD 1/24/2021 &  1220023549, BUD 2/9/2021.  b) Lot # 1220023040, BUD 1/19/2021; 1220023070, BUD 1/21/2021; 1220023105, BUD 1/25/2021; 1220023158, BUD 1/26/2021; 1220023315, BUD 2/1/2021; 1220023342, BUD 2/2/2021; 1220023431, BUD 2/4/2021;  1220023471, BUD 2/3/2021; 1220023481, BUD 2/4/2021 & 1220023509, BUD 2/8/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090687"], "brand_name": ["TACROLIMUS"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-720", "64380-721", "64380-722"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["198377", "198378", "313190"], "spl_id": ["48cd3633-d3c0-4197-aa6b-033887913404"], "spl_set_id": ["ed7d1495-3585-409d-94f1-b3d2469d222c"], "package_ndc": ["64380-720-06", "64380-720-01", "64380-721-06", "64380-721-01", "64380-722-01", "64380-722-06"], "is_original_packager": [true], "upc": ["0364380721062", "0364380720065", "0364380722069"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "87027", "recalling_firm": "Strides Pharma Inc.", "address_1": "2 Tower Center Blvd Ste 1102", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA", "recall_number": "D-0180-2021", "product_description": "NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816", "product_quantity": "960 bottles", "reason_for_recall": "Failed Moisture Limits", "recall_initiation_date": "20201222", "center_classification_date": "20201230", "termination_date": "20220126", "report_date": "20210106", "code_info": "Lot 7242728A; June 2023"}, {"status": "Terminated", "city": "Fairview", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87324", "recalling_firm": "Adams.Secret.co", "address_1": "29-31 Industrial Ave", "address_2": "N/A", "postal_code": "07022-1625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0311-2021", "product_description": "Adam's Secret Extra Strength 3000, 840 mg, 10 count blister packs, Distributed by AS Inc.,  Made in USA, UPC 6 09728 43452 6.", "product_quantity": "N/A", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of  tadalafil and sildenafil.", "recall_initiation_date": "20210215", "center_classification_date": "20210319", "termination_date": "20220420", "report_date": "20210331", "code_info": "All lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87283", "recalling_firm": "Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals", "address_1": "1919 N Victory Pl", "address_2": "N/A", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0304-2021", "product_description": "Spironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA, NDC 63629-1067-01", "product_quantity": "12 bottles", "reason_for_recall": "Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.", "recall_initiation_date": "20210127", "center_classification_date": "20210316", "report_date": "20210324", "code_info": "Lot #: 148992, Exp 5/31/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA210913"], "brand_name": ["CEQUA"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-506", "47335-507"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC", "TOPICAL"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["2055021", "2055026"], "spl_id": ["9db609da-42a0-42b1-87f5-020261a871ad"], "spl_set_id": ["48c3d8a3-4289-4b52-9189-58b48596095c"], "package_ndc": ["47335-506-96", "47335-507-97"], "is_original_packager": [true], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"]}, "product_type": "Drugs", "event_id": "87349", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Australia", "recall_number": "D-0289-2021", "product_description": "Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France  NDC 47335-506-96", "product_quantity": "37,400 cartons/60 vials per carton", "reason_for_recall": "Subpotent", "recall_initiation_date": "20210222", "center_classification_date": "20210226", "termination_date": "20220121", "report_date": "20210310", "code_info": "Lot 10007, exp. date 01/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87255", "recalling_firm": "Stanley Specialty Pharmacy Compounding and Wellness Center", "address_1": "3120 Latrobe Dr Ste 200", "address_2": "N/A", "postal_code": "28211-2185", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0252-2021", "product_description": "Lidocaine/Tetracaine (LIPO110)* 23%/7% Ointment 100 GMS per 4 ounce plastic ointment jar, Rx Only, Stanley Specialty Pharmacy 3120 Latrobe Dr. Suite 200 Charlotte, NC 28211", "product_quantity": "4400 grams (44 jars)", "reason_for_recall": "Superpotent Drug. Lidocaine   higher concentration than listed", "recall_initiation_date": "20210121", "center_classification_date": "20210210", "termination_date": "20220208", "report_date": "20210217", "code_info": "Lot: 195789 Exp. Apr. 17 2021"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0193-2021", "product_description": "fentaNYL 1500 mcg/30 mL (50 mcg/mL), 30 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004020016", "product_quantity": "2,834 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220022977, BUD 1/20/2021;  1220023122, BUD 1/25/2021; 1220023209, BUD 1/28/2021; 1220023248, BUD 1/27/2021; 1220023319, BUD 2/1/2021;  1220023496, BUD 2/8/2021 & 1220023560, BUD 2/9/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "San Nicolas De Los Georgia", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86078", "recalling_firm": "Liq-E S.A. De C.V.", "address_1": "Puerto Tampico 345", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the United States and Mexico.", "recall_number": "D-0254-2021", "product_description": "OPTIMUS LUBRICANTS Instant Hand Sanitizer, (alcohol 70% v/v) 55 Gal (208 L) drum, Made in Mexico, Liq-E, S.A. DE C.V., Puerto Tampico No. 345 Col.. La Fe San Nicolas de Los Garza, Nuevo Leon, Mexico. C.P. 66477.UPC # 7 501799 118998", "product_quantity": "575 drums", "reason_for_recall": "Chemical Contamination: Products contain methanol and were below the label claim for ethanol content", "recall_initiation_date": "20200720", "center_classification_date": "20210212", "termination_date": "20240408", "report_date": "20210224", "code_info": "Lot #  L-1160, L-2160, L-3160, L-1180, L-2180, L-2190, Exp. 05/2022; L-1200, L-2200, L-3200, L-4200, L-5200, L-1210 and L-2210, Exp. date 06/2022"}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87076", "recalling_firm": "Complete Pharmacy and Medical Solutions, LLC.", "address_1": "5829 Nw 158th St", "address_2": "N/A", "postal_code": "33014-6721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0234-2021", "product_description": "HUMAN CHORIONIC GONADOTROPIN 11,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035", "product_quantity": "1182 vials", "reason_for_recall": "CGMP deviations: Lack of potency testing.", "recall_initiation_date": "20201120", "center_classification_date": "20210119", "termination_date": "20220928", "report_date": "20210127", "code_info": "Lot #: 40568 Use By Date: 01/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0281-2021", "product_description": "MethyIPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL, 1 mL Single-Dose Vial (NDC 0703-0051-01), packaged in 25X1ML vials per tray (NDC 0703-0051-04), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454.", "product_quantity": "5,378 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327909B, exp. date 04/2021  Lot # 31328352B, exp. date 07/2021"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0196-2021", "product_description": "HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection (1 mg/mL) a) 30 mL Plungerless Single Dose Syringe (barcode 70004030316) and b) 30 mL Single Dose Syringe (barcode 70004030321), Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095", "product_quantity": "1,056 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "a) Lot # 1220022964, BUD 1/19/2021; 1220023280, BUD 2/1/2021 &  1220023623, BUD 2/10/2021.  b) Lot # 1220023347, BUD 2/17/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Madison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["REFRESH RELIEVA PRESERVATIVE FREE"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0023-6634"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM", "GLYCERIN"], "rxcui": ["1100650"], "spl_id": ["c6440fb1-2b9b-4531-90e5-32fd270915b7"], "spl_set_id": ["3481f9b3-5a90-40d3-80f8-81f51cc864be"], "package_ndc": ["0023-6634-10", "0023-6634-01", "0023-6634-20"], "is_original_packager": [true], "nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["K679OBS311", "PDC6A3C0OX"], "upc": ["300236634100"]}, "product_type": "Drugs", "event_id": "87016", "recalling_firm": "Allergan, PLC.", "address_1": "5 Giralda Farms", "address_2": "N/A", "postal_code": "07940-1027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0233-2021", "product_description": "Refresh Relieva PF Preservative-Free Lubricant Eye Drops 0.33 fl oz (10 mL) Sterile Distributed by: Allergan, an AbbVie company Madison, NJ 07940 UPC 3 00236 63410 0, NDC 0023-6634-10.", "product_quantity": "100,634 bottles", "reason_for_recall": "Labeling: Missing instructions for use insert", "recall_initiation_date": "20201230", "center_classification_date": "20210119", "termination_date": "20230621", "report_date": "20210127", "code_info": "Lots: T0392 Exp. Jul. 2022, T0843 Exp. Aug. 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA208347"], "brand_name": ["OSELTAMIVIR PHOSPHATE"], "generic_name": ["OSELTAMIVIR PHOSPHATE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-678"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OSELTAMIVIR PHOSPHATE"], "rxcui": ["1115698"], "spl_id": ["7916db0e-271a-45a3-be4f-5ab7838a3127"], "spl_set_id": ["b428e1f2-0082-4d9f-908e-e3633ea0457b"], "package_ndc": ["68180-678-01"], "is_original_packager": [true], "unii": ["4A3O49NGEZ"]}, "product_type": "Drugs", "event_id": "87195", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0247-2021", "product_description": "Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured for:Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad, Maharashtra, India. NDC: 68180-678-01", "product_quantity": "46,479 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point.", "recall_initiation_date": "20210121", "center_classification_date": "20210203", "termination_date": "20211216", "report_date": "20210210", "code_info": "Lot # A906423, exp. date Nov 2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87462", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0301-2021", "product_description": "Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07", "product_quantity": "8,183 unit dose cups", "reason_for_recall": "Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing", "recall_initiation_date": "20210308", "center_classification_date": "20210316", "termination_date": "20220809", "report_date": "20210324", "code_info": "Lot 369409, Exp. Date 05/2021; Lot 372393, Exp. Date 01/2022;  Lot 373112, Exp. Date 04/2022"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87135", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "N/A", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0238-2021", "product_description": "Ceftazidime Sterile Ophthalmic Solution for Injection Preservative Free 11.25mg / 0.5ml (22.5mg/ml) 0.5ml per syringe. KEEP FROZEN UNTIL USE AND PROTECT FROM LIGHT SINGLE USE SYRINGE FOR INTRAOCULAR INJECTION  Edge Pharma, LLC is an FDA-registered 503B outsourcing facility. This is a compounded (re-packaged) drug. Not for Resale, Hospital/Office use only. Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178", "product_quantity": "48 syringes", "reason_for_recall": "Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.", "recall_initiation_date": "20200319", "center_classification_date": "20210119", "termination_date": "20230607", "report_date": "20210127", "code_info": "Lot # 02-2020-04@4", "more_code_info": ""}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075520"], "brand_name": ["NORTRIPTYLINE HYDROCHLORIDE"], "generic_name": ["NORTRIPTYLINE HYDROCHLORIDE"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "product_ndc": ["51672-4001", "51672-4002", "51672-4003", "51672-4004"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NORTRIPTYLINE HYDROCHLORIDE"], "rxcui": ["198045", "198046", "198047", "317136"], "spl_id": ["7ff22c22-51b5-4ce3-93ee-8959359fab3c"], "spl_set_id": ["aee2c1a1-d848-4c3b-8c6d-8a4f6ce94c28"], "package_ndc": ["51672-4001-6", "51672-4001-5", "51672-4001-1", "51672-4001-2", "51672-4002-6", "51672-4002-4", "51672-4002-5", "51672-4002-1", "51672-4002-2", "51672-4003-6", "51672-4003-5", "51672-4003-1", "51672-4003-2", "51672-4004-6", "51672-4004-5", "51672-4004-1", "51672-4004-2"], "is_original_packager": [true], "upc": ["0351672400118", "0351672400316", "0351672400415"], "unii": ["00FN6IH15D"]}, "product_type": "Drugs", "event_id": "87152", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0246-2021", "product_description": "Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1", "product_quantity": "44,256 bottles", "reason_for_recall": "CGMP deviations.", "recall_initiation_date": "20210108", "center_classification_date": "20210201", "termination_date": "20230907", "report_date": "20210210", "code_info": "AC05096, AC05098, and AC05099; Exp 10/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0192-2021", "product_description": "fentaNYL 100 mcg/50mL Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 50 mL, 50 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals,755 Rainbow Rd., Windsor, CT, 06095, barcode 70004023122", "product_quantity": "996 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220022911, BUD 1/18/2021; 1220023092, BUD 1/25/2021 & 1220023247, BUD 1/27/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA073135"], "brand_name": ["METOCLOPRAMIDE"], "generic_name": ["METOCLOPRAMIDE"], "manufacturer_name": ["Teva Parenteral Medicines, Inc."], "product_ndc": ["0703-4502"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METOCLOPRAMIDE HYDROCHLORIDE"], "rxcui": ["311670"], "spl_id": ["e640a87c-7ee3-4ca2-9808-3916bfd1a54b"], "spl_set_id": ["cccf04bd-7463-40b8-a41f-cb1093c358d7"], "package_ndc": ["0703-4502-01", "0703-4502-04"], "is_original_packager": [true], "unii": ["W1792A2RVD"]}, "product_type": "Drugs", "event_id": "87330", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, including Puerto Rico", "recall_number": "D-0297-2021", "product_description": "Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)", "product_quantity": "9,452 cartons", "reason_for_recall": "Chemical contamination; Unknown brown residue adhering to the inside of one vial.", "recall_initiation_date": "20210215", "center_classification_date": "20210303", "termination_date": "20210826", "report_date": "20210310", "code_info": "Lot # 31325335B, exp. date 07/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87076", "recalling_firm": "Complete Pharmacy and Medical Solutions, LLC.", "address_1": "5829 Nw 158th St", "address_2": "N/A", "postal_code": "33014-6721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0235-2021", "product_description": "HUMAN CHORIONIC GONADOTROPIN 6,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035", "product_quantity": "2418 vials", "reason_for_recall": "CGMP deviations: Lack of potency testing.", "recall_initiation_date": "20201120", "center_classification_date": "20210119", "termination_date": "20220928", "report_date": "20210127", "code_info": "Lot# 40604 Use By date, 01/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210969"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-307"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["483017"], "spl_id": ["ddbd820d-6245-44a7-b539-3c6813ffa58a"], "spl_set_id": ["f80b6f72-f280-4b4a-a6a9-e6490b94705b"], "package_ndc": ["55150-307-01", "55150-307-24"], "is_original_packager": [true], "upc": ["0355150307012"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "87067", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0248-2021", "product_description": "Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose Vial, For Intravenous Use Only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 Made in India NDC 55150-307-01", "product_quantity": "3094 cartons", "reason_for_recall": "Discoloration and failed pH specifications", "recall_initiation_date": "20201230", "center_classification_date": "20210204", "termination_date": "20230919", "report_date": "20210210", "code_info": "CAT200002 exp 9/2022; CAT200004 exp 9/2022; CAT200005 exp 9/2022; CAT200008 exp 9/2022; CAT200009 exp 9/2022; CAT200013 exp 10/2022; CAT200014 exp 10/2022;  CAT200015 exp 10/2022; CAT200016 exp 10/2022; CAT200017 exp 10/2022; CAT200018 exp 10/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87498", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide", "recall_number": "D-0308-2021", "product_description": "Omeprazole Delayed-Release Capsules, USP, 20 mg, 1000 count bottles, Rx Only, distributed by Breckenridge Pharmaceutical, Inc., Berlin, CT, Manufactured by Tow Pharmaceutical Europe, S.L., Martorelles (Barcelona), Spain  NDC 51991-643-10", "product_quantity": "3,146 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.", "recall_initiation_date": "20210311", "center_classification_date": "20210318", "termination_date": "20220323", "report_date": "20210324", "code_info": "Lot # 191659, exp. date 05/2021"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87115", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "N/A", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0226-2021", "product_description": "Methotrexate, USP Sterile Solution for Injection, Preservative Free 125mg/5ml (25mg/ml), 5 mL per syringe, Rx Only, SYRINGE FOR IM INJECTION, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178, Barcode 0544650505", "product_quantity": "71 syringes", "reason_for_recall": "Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.", "recall_initiation_date": "20200319", "center_classification_date": "20210112", "termination_date": "20230607", "report_date": "20210120", "code_info": "Lot# 01-2020-28@10"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-544", "67877-545"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309113"], "spl_id": ["84f07b4a-a15e-41cb-af85-e110c5cf342e"], "spl_set_id": ["bb28751c-bd1b-4e7f-8271-a14c1b4314e3"], "package_ndc": ["67877-544-88", "67877-544-68", "67877-545-88", "67877-545-68"], "is_original_packager": [true], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "87032", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0178-2021", "product_description": "Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 100 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88", "product_quantity": "29,317 bottles", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20201217", "center_classification_date": "20201230", "termination_date": "20230503", "report_date": "20210106", "code_info": "20141674, 20141675, 20141676, 20141677, 20141678,"}, {"status": "Terminated", "city": "San Nicolas De Los Georgia", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86078", "recalling_firm": "Liq-E S.A. De C.V.", "address_1": "Puerto Tampico 345", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the United States and Mexico.", "recall_number": "D-0255-2021", "product_description": "OPTIMUS LUBRICANTS Instant Hand Sanitizer, (ethyl alcohol 70%) 1 Gal (3.78 L) bottle, Made in Mexico, Liq-E, S.A. DE C.V., Puerto Tampico No. 345 Col. La Fe San Nicolas de Los Garza, Nuevo Leon, Mexico. C.P. 66477; NDC: XXXXX-378-04, UPC # 7 501799 118837", "product_quantity": "6,597 gallons", "reason_for_recall": "Chemical Contamination: Products contain methanol and were below the label claim for ethanol content", "recall_initiation_date": "20200720", "center_classification_date": "20210212", "termination_date": "20240408", "report_date": "20210224", "code_info": "Lot # (L) 20-03, exp. date 05/22"}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87458", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "GA", "recall_number": "D-0300-2021", "product_description": "Nortriptyline HCL capsules, 10 mg, packaged in 30-count bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA, NDC 6191985330", "product_quantity": "17 bottles", "reason_for_recall": "cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that specific lot was formally qualified for use by the manufacturing site.", "recall_initiation_date": "20210302", "center_classification_date": "20210312", "termination_date": "20210921", "report_date": "20210324", "code_info": "Lot#: 28DE2002 Exp 10/31/22"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["42641d19-c870-7770-e063-6294a90acf97"], "spl_set_id": ["8529596f-37e4-c44e-e053-2a91aa0ad014"], "package_ndc": ["54365-400-32"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "86998", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in Puerto Rico and Oman", "recall_number": "D-0265-2021", "product_description": "BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Sterile Solution, 0.10 fl. oz. (3 ml) each, 25 Applicators in carton, CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-32 REF 930400", "product_quantity": "988 cartons", "reason_for_recall": "Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20200707", "center_classification_date": "20210219", "termination_date": "20220929", "report_date": "20210303", "code_info": "All lots including but not limited to the following lots distributed in Zone IV:  Lot # 0161217 Exp. 05/31/2023; 0211068 Exp. 07/31/2023; 0176660 Exp. 06/30/2023; 0188805 Exp. 06/30/2023; 0175874 Exp. 06/30/2023; 0151977 Exp. 05/31/2023; 0149328 Exp. 04/30/2023; 0085419 Exp. 03/31/2023"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0278-2021", "product_description": "Toposar (etoposide injection USP), 1 gram/50 mL (20 mg/mL), 50 mL Multiple-dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-5657-01.", "product_quantity": "4,806 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot #   31327600B, exp. date 08/2022"}, {"status": "Terminated", "city": "Spring Park", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87037", "recalling_firm": "Shane Erickson Inc", "address_1": "4284 Shoreline Dr", "address_2": "", "postal_code": "55384-9652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Canada", "recall_number": "D-0239-2021", "product_description": "IMC Wash-Free Hand Sanitizer, (ethyl alcohol), 75%, 1.7 fl. oz. (50 ml) bottles, Distributed by IMC 4284 Shoreline Dr, Spring Park, MN 55384, Made in China, ALSO distributed with Custom front labels as follows a) Sadie G. Mays Health & Rehabilitation Center, b) Pacers logo, c) northwood CHURCH, d) ROGERTHEROOFER.com and e) SoFi Stadium Wash-Free Hand Sanitizer. UPC 8 19845 00597 8", "product_quantity": "36,505 bottles", "reason_for_recall": "CGMP Deviations: product manufactured at the same facility that produced product that FDA sampled and found to be subpotent for ethanol and contained methanol.", "recall_initiation_date": "20201223", "center_classification_date": "20210122", "termination_date": "20230929", "report_date": "20210203", "code_info": "Lot 2020/05/11, exp 2023/05/10", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0201-2021", "product_description": "Morphine Sulfate 3 mg/3 mL in 0.9% Sodium Chloride (1mg/mL) CII, Rx Only, 3 ml Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010025", "product_quantity": "751 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023452, BUD 2/7/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Spring Park", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87037", "recalling_firm": "Shane Erickson Inc", "address_1": "4284 Shoreline Dr", "address_2": "", "postal_code": "55384-9652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Canada", "recall_number": "D-0240-2021", "product_description": "IMC Wash-Free Hand Sanitizer, (ethyl alcohol), 75%, 3.4 fl. oz. (100 ml), Made in China, Distributed by IMC 4284 Shoreline Dr, Spring Park, MN 55384. Labeled as a)  SAFE-GUARD Products International, b) Safe-WAY JEVCO Wash-Free Hand Sanitizer, c) TRACTION CAPITAL, d) United States Census 2020. UPC 8 19845 00598 5", "product_quantity": "42,157 bottles", "reason_for_recall": "CGMP Deviations: product manufactured at the same facility that produced product that FDA sampled and found to be subpotent for ethanol and contained methanol.", "recall_initiation_date": "20201223", "center_classification_date": "20210122", "termination_date": "20230929", "report_date": "20210203", "code_info": "Lot: MFG: 2020/05/10 L/N: 20200510-3", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0210-2021", "product_description": "PHENYLephrine HCl 500 mcg/5mL in 0.9% Sodium Chloride (100 mcg/mL), Rx Only,  5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004081011", "product_quantity": "14,580 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot #    1220022958, BUD 1/20/2021;  1220023013, BUD 1/18/2021;  1220023035, BUD 1/19/2021;  1220023036, BUD 1/21/2021;   1220023059, BUD 1/21/2021;   1220023094, BUD 1/25/2021;  1220023167, BUD 1/26/2021;  1220023208, BUD 1/27/2021;  1220023291, BUD 1/31/2021;  1220023359, BUD 2/2/2021;  1220023401, BUD 2/2/2021 &  1220023473, BUD 2/4/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA200535"], "brand_name": ["OXYCODONE HYDROCHLORIDE"], "generic_name": ["OXYCODONE HYDROCHLORIDE"], "manufacturer_name": ["Genus Lifesciences Inc."], "product_ndc": ["64950-353", "64950-354"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OXYCODONE HYDROCHLORIDE"], "rxcui": ["1049604", "1049615"], "spl_id": ["c3401720-9c93-41af-b73f-638bc13cb09e"], "spl_set_id": ["6869fec9-1837-4221-afd8-5cc6fadd025d"], "package_ndc": ["64950-353-03", "64950-353-01", "64950-353-91", "64950-353-51", "64950-353-02", "64950-353-92", "64950-353-52", "64950-354-10", "64950-354-50", "64950-354-05", "64950-354-55", "64950-354-45"], "is_original_packager": [true], "upc": ["0364950353037", "0364950354058"], "unii": ["C1ENJ2TE6C"]}, "product_type": "Drugs", "event_id": "87044", "recalling_firm": "Genus Lifesciences Inc.", "address_1": "514 N 12th St", "address_2": "N/A", "postal_code": "18102-2756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0231-2021", "product_description": "Oxycodone Hydrochloride Oral Solution, USP 5 mg/5mL unit dose cups, Rx Only, Genus Lifesciences Inc. NDC 64950-354-05 Case NDC: 64950-354-450(40 unit dose cups) Case NDC 64950-354-55 (50 unit dose cups)", "product_quantity": "1,171,550 cups", "reason_for_recall": "Presence of Foreign Substance: Particulate matter was found in multiple lots of product.", "recall_initiation_date": "20201223", "center_classification_date": "20210115", "termination_date": "20211105", "report_date": "20210120", "code_info": "Lot # 35400119A, 35400219A, 35400319A, 35400419A , 35400519A , 35400619A, EXP 12/31/20; 35400719A, 35400819A, EXP 1/31/21;  35400919A, 35401019A, 35401119A, EXP 2/28/21; 35401219A, 35401319A, EXP 4/30/21; 35401419A, 35401519A, 35401619A, EXP 5/31/21; 35401719A,  35401819A, EXP 7/31/21; 35401919A, 35402019A, EXP 8/31/21; 35402119A,  35402219A, 35402319A, 35402419A, EXP 9/30/21; 35402519A, EXP 10/31/21;  35402619A, 35402719A, EXP 11/30/21; 35400120A, 35400220A,   35400320A, 35400420B, EXP 12/31/21; 35400520A, EXP 1/31/22, 35400620A, EXP 1/31/22."}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87566", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Sold to two wholesalers/distributors under government contract located in PA and TX", "recall_number": "D-0312-2021", "product_description": "Omeprazole Delayed Release Capsules, USP, 20 mg, 1000-count bottles, Rx only, Packaged by GSMS Incorporated, Camarillo, CA 93012-8601 USA, NDC 51407-129-10", "product_quantity": "N/A", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer", "recall_initiation_date": "20210319", "center_classification_date": "20210324", "termination_date": "20210728", "report_date": "20210331", "code_info": "Lot #: GS029673, Exp. Date 5/2021", "more_code_info": ""}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["42b89ed3-8625-c3c3-e063-6294a90afa62"], "spl_set_id": ["85416361-90b5-3efa-e053-2a91aa0af431"], "package_ndc": ["54365-400-33"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "86998", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in Puerto Rico and Oman", "recall_number": "D-0268-2021", "product_description": "BD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Sterile Solution, 0.01 fl. oz. (3 ml) each, 25 Applicators in carton,  CareFusion El Paso, TX 79912, subsidiary of Becton, Dickinson and Co., NDC 54365-400-33 REF 930415", "product_quantity": "400 cartons", "reason_for_recall": "Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20200707", "center_classification_date": "20210219", "termination_date": "20220929", "report_date": "20210303", "code_info": "All lots including but not limited to the following lots distributed in Zone IV: Lot # 0107872, Exp. 04/30/2023; 0108556, Exp. 04/30/2023; 0148278, Exp. 04/30/2023; 0151978, Exp. 05/31/2023; 0155534, Exp. 05/31/2023; 0157085, Exp. 05/31/2023; 0160618, Exp. 05/31/2023; 0167907, Exp. 05/31/2023."}, {"status": "Terminated", "city": "Boston", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204333"], "brand_name": ["FLUDEOXYGLUCOSE F 18"], "generic_name": ["FLUDEOXYGLUCOSE F-18"], "manufacturer_name": ["Massachusetts General Hospital"], "product_ndc": ["76318-334"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["FLUDEOXYGLUCOSE F-18"], "spl_id": ["d6019460-717e-4285-9582-06646e8f778a"], "spl_set_id": ["232fbb91-402e-44d8-a0cf-6813980b8ead"], "package_ndc": ["76318-334-50"], "is_original_packager": [true], "nui": ["N0000177914", "N0000000205"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "unii": ["0Z5B2CJX4D"]}, "product_type": "Drugs", "event_id": "87384", "recalling_firm": "The General Hospital Corporation", "address_1": "55 Fruit St", "address_2": "N/A", "postal_code": "02114-2621", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was distributed to one direct account.", "recall_number": "D-0288-2021", "product_description": "Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA  NDC 76318-334-50", "product_quantity": "50 mL vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210217", "center_classification_date": "20210224", "termination_date": "20210326", "report_date": "20210303", "code_info": "Lot # P01-021721, exp 02/17/2021"}, {"status": "Ongoing", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87283", "recalling_firm": "Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals", "address_1": "1919 N Victory Pl", "address_2": "N/A", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0303-2021", "product_description": "Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-count bottles (NDC 63629-1064-02), c) 90-count bottles (NDC 63629-1064-03), Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA", "product_quantity": "35 bottles", "reason_for_recall": "Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.", "recall_initiation_date": "20210127", "center_classification_date": "20210316", "report_date": "20210324", "code_info": "a) Lot #: 148969, Exp 7/31/2022, b) Lot #: 148791, Exp 7/31/2022, c) Lot #: 148991, Exp 7/31/2022"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA213238"], "brand_name": ["GLYCOPYRROLATE"], "generic_name": ["GLYCOPYRROLATE"], "manufacturer_name": ["Accord Healthcare, Inc.,"], "product_ndc": ["16729-471", "16729-472", "16729-473", "16729-474"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["GLYCOPYRROLATE"], "rxcui": ["238212", "1731582", "1731590"], "spl_id": ["415de5a5-d773-4816-e063-6294a90a6853"], "spl_set_id": ["871797f0-697a-4a29-a37b-d06219e8f266"], "package_ndc": ["16729-471-08", "16729-472-08", "16729-473-03", "16729-474-03", "16729-474-05", "16729-472-30"], "is_original_packager": [true], "upc": ["0316729474054", "0316729472302", "0316729473316", "0316729471633"], "unii": ["V92SO9WP2I"]}, "product_type": "Drugs", "event_id": "87233", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0250-2021", "product_description": "Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703, USA.  Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad-382 210, India NDC 16729-472-08 (Vial NDC 16729-472-30)", "product_quantity": "502 cartons", "reason_for_recall": "Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials", "recall_initiation_date": "20210128", "center_classification_date": "20210208", "termination_date": "20220208", "report_date": "20210217", "code_info": "Lot: M2013645 Exp. Aug. 2022"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0274-2021", "product_description": "Epoprostenol Sodium for Injection, 0.5 mg/vial (500,000 ng),  1X10ML vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-1985-01.", "product_quantity": "12,629 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327537B, exp. date 09/2021"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87348", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "N/A", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0306-2021", "product_description": "Methacholine Challenge 5-Syringe Test Kits, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr., Dolchester, VT 06448  NDC # 05446-1600-05", "product_quantity": "213 kits", "reason_for_recall": "Temperature Abuse; labeled with the incorrect room temperature (15-25 \u00bfC) storage conditions rather than the correct refrigerated (2 - 8 \u00bfC) storage conditions", "recall_initiation_date": "20210217", "center_classification_date": "20210318", "termination_date": "20210610", "report_date": "20210324", "code_info": "Lot # 12-2020-16@10, BUD 3-30-21   Lot # 11-2020-18@11, BUD 3-02-21"}, {"status": "Ongoing", "city": "Monterey", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87101", "recalling_firm": "NDAL Mfg Inc.", "address_1": "23745 Spectacular Bid Ln", "address_2": "N/A", "postal_code": "93940-6527", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA and Hong Kong", "recall_number": "D-0269-2021", "product_description": "ManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray, 1.3 FL OZ (40mL) bottle, 270 measured sprays, Distributed by Ndal Laboratories, 449 Alvarado St., Monterey, CA 93940 (bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA  93940 (carton); UPC 8 58631 00212 8.    the Alvarado St. is for the bottle by putting \"(bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA  93940 (carton); UPC 8 58631 00212 8.\" (according to the label)", "product_quantity": "4265 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product confirmed to have yeast", "recall_initiation_date": "20201217", "center_classification_date": "20210219", "report_date": "20210303", "code_info": "LOT # 2010045; Best Before 10 2023"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0284-2021", "product_description": "MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL), 5 mL Multiple-Dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-0063-01.", "product_quantity": "15,043 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327738B, exp. date 03/2021"}, {"status": "Ongoing", "city": "Tonala", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86898", "recalling_firm": "GAZA PROVEEDORA DE SERVICIOS DE HOSPEDAJE Y ALIMENTACION", "address_1": "Castilla 1473a Coloniajardines De", "address_2": "Tonala", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0230-2021", "product_description": "Zapien Productos Hand Sanitizer Gel Antibacterial, 33.8 FL. OZ (1000 mL), Made by GAZA S.A. DE C.V. Castilla St. #1473-A ZIP 45410 Tonala, Jalisco, Mexico, UPC: 7 501700 623504, NDC numbers: 76938-001-01, 76938-001-02, 76938-001-03.", "product_quantity": "43875 liters", "reason_for_recall": "cGMP deviations: Product made at the same facility where product tested was sub-potent.", "recall_initiation_date": "20201201", "center_classification_date": "20210114", "report_date": "20210120", "code_info": "All Lots"}]